Treatment of Rifampin-resistsant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr Ukraine

Project Details


The study aims at identifying ways to improve the care of people with RR/MDR-TB in Ukraine.
The specific goal of this study is to describe the effectiveness, safety, tolerability and feasibility of an all-oral 9 to 12 month-regimen containing new drugs for the treatment of RR/MDR-TB in Zhytomyr, Ukraine.
Effective start/end date1/03/1931/07/21


  • Médecins Sans Frontières: €107,943.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.